NCT05366062 2022-05-13ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and PembrolizumabEpitopoietic Research CorporationPhase 2 Not yet recruiting28 enrolled